Related Experiment Video
Updated: Apr 23, 2026
10:12
Enrichment of Mammalian Tissues and Xenopus Oocytes with Cholesterol
Published on: March 25, 2020
5.6K
Cholesterol in brain disease: sometimes determinant and frequently implicated
Mauricio G Martín1, Frank Pfrieger2, Carlos G Dotti3
1Instituto de Investigaciones Médicas Mercedes y Martín Ferreyra (INIMEC-CONICET-UNC), Universidad Nacional de Córdoba, Córdoba, Argentina mmartin@immf.uncor.edu frank.pfrieger@inci-cnrs.unistra.fr cdotti@cbm.csic.es.
EMBO Reports
|September 17, 2014
Summary
Cholesterol is vital for brain function and development. Disruptions in cholesterol metabolism are linked to neurodegenerative diseases like Alzheimer's and Parkinson's, impacting synaptic function.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Cholesterol is crucial for neuronal membrane structure and function.
- Hereditary cholesterol defects impair brain development.
- Altered cholesterol metabolism is implicated in neurodegenerative diseases and aging.
Purpose of the Study:
- To review causes of cholesterol dyshomeostasis and their link to brain diseases.
- To explore how cholesterol metabolism affects synaptic function.
Main Methods:
- Literature review of hereditary and non-hereditary cholesterol disorders.
- Analysis of cholesterol's role in synaptic plasticity and function.
Main Results:
- Cholesterol dyshomeostasis arises from genetic and non-genetic factors.
- Impaired cholesterol metabolism contributes to neurological conditions and cognitive decline.
- Synaptic function is sensitive to alterations in brain cholesterol levels.
Conclusions:
- Understanding cholesterol's role is key to addressing brain diseases.
- Targeting cholesterol metabolism may offer therapeutic strategies for neurological disorders.
Related Concept Videos
01:23Alzheimer Disease ll: Pathophysiology
16
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
16
01:29Cholesterol: Significance and Regulation
1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.9K
01:23Role of Neurotransmitters in Memory
2.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.8K
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:29Alzheimer Disease l: Introduction
13
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
13